
TY  - JOUR
TI  - 37th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF)
JO  - Experimental Dermatology
VL  - 19
IS  - 2
SN  - 0906-6705
UR  - https://doi.org/10.1111/j.1600-0625.2009.01051.x
DO  - doi:10.1111/j.1600-0625.2009.01051.x
SP  - 166
EP  - 232
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Basic & Clinical Pharmacology & Toxicology
JA  - Basic Clin Pharmacol Toxicol
VL  - 125
IS  - S10
SN  - 1742-7835
UR  - https://doi.org/10.1111/bcpt.13363
DO  - doi:10.1111/bcpt.13363
SP  - 3
EP  - 156
PY  - 2019
ER  - 

TY  - JOUR
AU  - Loera-Valencia, R.
AU  - Cedazo-Minguez, A.
AU  - Kenigsberg, P.A.
AU  - Page, G.
AU  - Duarte, A.I.
AU  - Giusti, P.
AU  - Zusso, M.
AU  - Robert, P.
AU  - Frisoni, G. B.
AU  - Cattaneo, A.
AU  - Zille, M.
AU  - Boltze, J.
AU  - Cartier, N.
AU  - Buee, L.
AU  - Johansson, G.
AU  - Winblad, B.
TI  - Current and emerging avenues for Alzheimer's disease drug targets
JO  - Journal of Internal Medicine
JA  - J Intern Med
VL  - 286
IS  - 4
SN  - 0954-6820
UR  - https://doi.org/10.1111/joim.12959
DO  - doi:10.1111/joim.12959
SP  - 398
EP  - 437
KW  - AD gene therapy
KW  - AD molecular targets
KW  - AD therapeutics
KW  - alzheimer´s disease
KW  - amyloid beta therapies
KW  - Tau therapies
PY  - 2019
AB  - Abstract Alzheimer's disease (AD), the most frequent cause of dementia, is escalating as a global epidemic, and so far, there is neither cure nor treatment to alter its progression. The most important feature of the disease is neuronal death and loss of cognitive functions, caused probably from several pathological processes in the brain. The main neuropathological features of AD are widely described as amyloid beta (A?) plaques and neurofibrillary tangles of the aggregated protein tau, which contribute to the disease. Nevertheless, AD brains suffer from a variety of alterations in function, such as energy metabolism, inflammation and synaptic activity. The latest decades have seen an explosion of genes and molecules that can be employed as targets aiming to improve brain physiology, which can result in preventive strategies for AD. Moreover, therapeutics using these targets can help AD brains to sustain function during the development of AD pathology. Here, we review broadly recent information for potential targets that can modify AD through diverse pharmacological and nonpharmacological approaches including gene therapy. We propose that AD could be tackled not only using combination therapies including A? and tau, but also considering insulin and cholesterol metabolism, vascular function, synaptic plasticity, epigenetics, neurovascular junction and blood?brain barrier targets that have been studied recently. We also make a case for the role of gut microbiota in AD. Our hope is to promote the continuing research of diverse targets affecting AD and promote diverse targeting as a near-future strategy.
ER  - 

TY  - JOUR
TI  - Abstract Presentations from the AABB Annual Meeting Boston, MA, October 13–16, 2018
JO  - Transfusion
JA  - Transfusion
VL  - 58
IS  - S2
SN  - 0041-1132
UR  - https://doi.org/10.1111/trf.14903
DO  - doi:10.1111/trf.14903
SP  - 6A
EP  - 254A
PY  - 2018
ER  - 

TY  - JOUR
AU  - Nooshabadi, Vajihe Taghdiri
AU  - Mardpour, Soura
AU  - Yousefi-Ahmadipour, Aliakbar
AU  - Allahverdi, Amir
AU  - Izadpanah, Mehrnaz
AU  - Daneshimehr, Fatemeh
AU  - Ai, Jafar
AU  - Banafshe, Hamid R.
AU  - Ebrahimi-Barough, Somayeh
TI  - The extracellular vesicles-derived from mesenchymal stromal cells: A new therapeutic option in regenerative medicine
JO  - Journal of Cellular Biochemistry
JA  - J. Cell. Biochem.
VL  - 119
IS  - 10
SN  - 0730-2312
UR  - https://doi.org/10.1002/jcb.26726
DO  - doi:10.1002/jcb.26726
SP  - 8048
EP  - 8073
KW  - exosome
KW  - extracellular vesicles
KW  - mesenchymal stem cells
KW  - regenerative medicine
PY  - 2018
AB  - Abstract Mesenchymal stem cells (MSCs) are adult multipotent cells that due to their ability to homing to damaged tissues and differentiate into specialized cells, are remarkable cells in the field of regenerative medicine. It's suggested that the predominant mechanism of MSCs in tissue repair might be related to their paracrine activity. The utilization of MSCs for tissue repair is initially based on the differentiation ability of these cells; however now it has been revealed that only a small fraction of the transplanted MSCs actually fuse and survive in host tissues. Indeed, MSCs supply the microenvironment with the secretion of soluble trophic factors, survival signals and the release of extracellular vesicles (EVs) such as exosome. Also, the paracrine activity of EVs could mediate the cellular communication to induce cell-differentiation/self-renewal. Recent findings suggest that EVs released by MSCs may also be critical in the physiological function of these cells. This review provides an overview of MSC-derived extracellular vesicles as a hopeful opportunity to advance novel cell-free therapy strategies that might prevail over the obstacles and risks associated with the use of native or engineered stem cells. EVs are very stable; they can pass the biological barriers without rejection and can shuttle bioactive molecules from one cell to another, causing the exchange of genetic information and reprogramming of the recipient cells. Moreover, extracellular vesicles may provide therapeutic cargo for a wide range of diseases and cancer therapy.
ER  - 

TY  - JOUR
TI  - Oral presentations
JO  - Clinical Microbiology and Infection
VL  - 17
IS  - s4
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2011.03557.x
DO  - doi:10.1111/j.1469-0691.2011.03557.x
SP  - S1
EP  - S107
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstract Presentations from the AABB Annual Meeting and CTTXPO, Denver, CO, October 12-15, 2013
JO  - Transfusion
JA  - Transfusion
VL  - 53
IS  - S2
SN  - 0041-1132
UR  - https://doi.org/10.1111/trf.12401
DO  - doi:10.1111/trf.12401
SP  - 11A
EP  - 218A
PY  - 2013
ER  - 

TY  - JOUR
TI  - Poster Session 2, Monday 27 September
JO  - European Journal of Neurology
VL  - 17
IS  - s3
SN  - 1351-5101
UR  - https://doi.org/10.1111/j.1468-1331.2010.03233.x
DO  - doi:10.1111/j.1468-1331.2010.03233.x
SP  - 351
EP  - 625
PY  - 2010
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Journal of Gastroenterology and Hepatology
VL  - 26
IS  - s5
SN  - 0815-9319
UR  - https://doi.org/10.1111/j.1440-1746.2011.06898.x
DO  - doi:10.1111/j.1440-1746.2011.06898.x
SP  - 16
EP  - 288
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster sessions WTH Wednesday/Thursday
JO  - Journal of Neurochemistry
JA  - J. Neurochem.
VL  - 142
IS  - S1
SN  - 0022-3042
UR  - https://doi.org/10.1111/jnc.14094
DO  - doi:10.1111/jnc.14094
SP  - 165
EP  - 259
PY  - 2017
ER  - 

TY  - JOUR
TI  - Poster Presentation Abstracts
JO  - International Journal of Laboratory Hematology
JA  - Int. Jnl. Lab. Hem.
VL  - 36
IS  - s1
SN  - 1751-5521
UR  - https://doi.org/10.1111/ijlh.12266
DO  - doi:10.1111/ijlh.12266
SP  - 30
EP  - 131
PY  - 2014
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Acta Ophthalmologica
JA  - Acta Ophthalmol
VL  - 96
IS  - S260
SN  - 1755-375X
UR  - https://doi.org/10.1111/aos.13736
DO  - doi:10.1111/aos.13736
SP  - 3
EP  - 49
PY  - 2018
ER  - 

TY  - JOUR
TI  - 139th Annual Meeting American Neurological Association
JO  - Annals of Neurology
JA  - Ann Neurol.
VL  - 76
IS  - S18
SN  - 0364-5134
UR  - https://doi.org/10.1002/ana.24247
DO  - doi:10.1002/ana.24247
SP  - S1
EP  - S151
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - European Journal of Immunology
JA  - Eur. J. Immunol.
VL  - 39
IS  - S1
SN  - 0014-2980
UR  - https://doi.org/10.1002/eji.200990224
DO  - doi:10.1002/eji.200990224
SP  - S55
EP  - S279
PY  - 2009
AB  - Abstract No Abtract
ER  - 

TY  - JOUR
TI  - 10th International Conference on Frontotemporal Dementias Munich/Germany; August 31-September 2, 2016
JO  - Journal of Neurochemistry
JA  - J. Neurochem.
VL  - 138
IS  - S1
SN  - 0022-3042
UR  - https://doi.org/10.1111/jnc.13692
DO  - doi:10.1111/jnc.13692
SP  - 222
EP  - 428
PY  - 2016
ER  - 

TY  - JOUR
TI  - 30th Annual Meeting of the Wound Healing Society SAWC-Spring/WHS Joint Meeting: Charlotte Convention Center, Charlotte, North Carolina, USA April 25–29, 2018
JO  - Wound Repair and Regeneration
JA  - Wound Rep Reg
VL  - 26
IS  - 1
SN  - 1067-1927
UR  - https://doi.org/10.1111/wrr.12622
DO  - doi:10.1111/wrr.12622
SP  - A1
EP  - A42
PY  - 2018
ER  - 

TY  - JOUR
TI  - British Society for Matrix Biology – Spring 2012 Meeting Report
JO  - International Journal of Experimental Pathology
JA  - Int. J. Exp. Path.
VL  - 94
IS  - 1
SN  - 0959-9673
UR  - https://doi.org/10.1111/iep.12004
DO  - doi:10.1111/iep.12004
SP  - A1
EP  - A48
PY  - 2013
ER  - 

TY  - JOUR
TI  - The British Microcirculation Society Abstracts of the 64th annual meeting in University of Bristol
JO  - Microcirculation
JA  - Microcirculation
VL  - 22
IS  - 5
SN  - 1073-9688
UR  - https://doi.org/10.1111/micc.12204
DO  - doi:10.1111/micc.12204
SP  - 400
EP  - 430
PY  - 2015
ER  - 

TY  - JOUR
TI  - ASBMR 30th Annual Meeting M001–M507
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 23
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650231306
DO  - doi:10.1002/jbmr.5650231306
SP  - S374
EP  - S505
PY  - 2008
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Asia-Pacific Journal of Clinical Oncology
JA  - Asia‐Pac J Clin Oncol
VL  - 10
IS  - S9
SN  - 1743-7555
UR  - https://doi.org/10.1111/ajco.12332
DO  - doi:10.1111/ajco.12332
SP  - 1
EP  - 264
PY  - 2014
ER  - 
